Progress on Diabetes, Cancer Treatments


Published On: January 15th, 2010

Anna Gluskin, CEO of Generex Biotechnology, talks about the company’s oral treatment for diabetes along with a cancer vaccine under development. MarketWatch’s Kristen Gerencher reports from the J.P. Morgan health-care conference in San Francisco.

Read the original here:
Progress on Diabetes, Cancer Treatments/a>



Loading...


Comments are closed.